Our Blog

Cynata Therapeutics (ASX:CYP) 1H20 results & outlook

31 Mar 2020 – Cynata Therapeutics Limited (ASX:CYP) Managing Director, Dr Ross MacDonald, talks 1H20 results, upcoming Phase 2 clinical trials, licensing and strategy to build the company’s Cymerus cell therapy platform.


Source: Finance News Network

Share this post